LC
BSX icon

Lourd Capital’s Boston Scientific BSX Stock Holding History

Lourd Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-16,880
Closed -$597K – 151
2018
Q4 		$597K Sell
16,880
-409
-2% -$14.8K 0.05% 100
2018
Q3 		$666K Buy
17,289
+124
+0.7% +$4.33K 0.04% 100
2018
Q2 		$561K Buy
17,165
+21
+0.1% +$633 0.08% 75
2018
Q1 		$468K Buy
17,144
+23
+0.1% +$625 0.06% 94
2017
Q4 		$424K Buy
+17,121
New +$472K 0.03% 182

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Lourd Capital's BSX Position: Q1 2019 in Review

Lourd Capital sold out of Boston Scientific (BSX) in Q1 2019, closing a stake of 16,880 shares — an estimated $597K sold.

Lourd Capital first reported a position in BSX in Q4 2017 and held it in 5 quarters. The position peaked at $666K in Q3 2018. 788 funds tracked by Wall St. Rank hold BSX as of Q1 2019.

  • Lourd Capital reported no remaining Boston Scientific position as of Q1 2019 after selling out during the quarter.
  • Lourd Capital sold 16,880 Boston Scientific shares in Q1 2019, an estimated $597K.
  • Lourd Capital first reported a position in Boston Scientific in Q4 2017 and held it in 5 quarters.
  • Lourd Capital's Boston Scientific position peaked at $666K in Q3 2018.
  • 788 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2019.

Based on Lourd Capital's 13F filing for Q1 2019, filed 16 Apr 2019.